CV Sciences, Inc. Stock Price - CVSI

Best deals to access real time data!
Monthly Subscription
for only
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 0.32 ▲ 0.00 (0.10%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Cv Sciences, Inc. (QB) CVSI Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00 +0.00% 0.32 0.34 0.3111 0.3255 0.32 16:12:30
Bid Price Ask Price Spread Spread % News
0.3111 0.32 0.0089 2.78% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
102 186,663 $ 0.3266 $ 60.97k 488.04k 0.19 - 0.99
Last Trade Time Type Quantity Stock Price Currency
16:16:06 formt 9,450 $0.32 USD

Cv Sciences, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 20.08M 62.75M $ -14.14M - -1.42 49.84M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
50.25k 0.08% $ - 0.00% - -

more financials information »

Cv Sciences, Inc. (QB) News

Historical CVSI Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.36990.370.31110.0000145k456k296k-0.0499-13.49%
1 Month0.4060.41890.31110.0000145k456k270k-0.086-21.18%
3 Months0.48250.5450.31110.0000145k2M469k-0.1625-33.68%
6 Months0.7450.98660.2550.0000145k4M903k-0.425-57.05%
1 Year0.4950.98660.1930.00007k4M662k-0.175-35.35%
3 Years18.5021.250.100.000004M377k-18.18-98.27%
5 Years15.00205.000.00010.000004M276k-14.68-97.87%

Cv Sciences, Inc. (QB) Description

CV Sciences, Inc. is a life science company that operates through two segments, specialty pharmaceuticals and consumer products. The Company focuses on developing and commercializing proprietary prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient and is engaged in the development, manufacturing, marketing and sale of consumer products containing plant-based CBD, which is refined into its own proprietary branded products. CV Sciences initial drug candidate (CVSI-007) is a chewing gum that combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at $2 billion, growing to over $4 billion in the next 5-6 years.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.